Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On November 6, 2026, Q/C Technologies, Inc. (the “ Company ”) received a letter from the Listing Qualifications staff of The Nasdaq Stock Market (“ Nasdaq ”) notifying the Company that, based on the closing bid price of the Company’s common stock for the last 30 consecutive business days…
Filed Nov 13, 2026Accepted Nov 13, 2026, 5:00 PM ESTCIK 1321834Accession 0001493152-26-051808
Q/C Technologies believes the next leap in frontier computing is optical. The Company is pioneering next-generation optical computing solutions designed to harness the properties of light to perform complex computations naturally via interference. Overcoming key challenges posed by electronic GPUs, Q/C Technologies seeks to develop proprietary optical processing units with orders of magnitude faster clock speed and bandwidth and vastly improved energy efficiency relative to traditional computing architectures. qctechnologies.com
Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 3.01Item 3.01 - Notice of Delisting
Item
3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
On
November 6, 2026, Q/C Technologies, Inc. (the “ Company ”) received a letter from the Listing Qualifications staff of
The Nasdaq Stock Market (“ Nasdaq ”) notifying the Company that, based on the closing bid price of the Company’s
common stock for the last 30 consecutive business days from September 25, 2026 to November 5, 2026, the Company no longer meets the continued
listing requirement of Nasdaq under Nasdaq Listing Rule 5550(a)(2) to maintain a minimum bid price of $1.00 per share.
Nasdaq
has provided the Company with a 180 calendar day compliance period, or until May 5, 2027, in which to regain compliance with Nasdaq’s
continued listing requirement. In the event that the Company does not regain compliance in the compliance period, the Company may be
eligible for an additional 180 calendar days, should the Company meet the continued listing requirement for market value of publicly
held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the bid price requirement, and
is able to provide written notice of its intention to cure the deficiency during the second compliance period, by effecting a reverse
stock split, if necessary. However, if it appears that the Company will not be able to cure the deficiency, or if the Company is otherwise
not eligible, Nasdaq will provide notice that the Company’s securities will be subject to delisting.
The
Company is currently evaluating options to regain compliance and intends to timely regain compliance with Nasdaq’s continued listing
requirement. Although the Company will use all reasonable efforts to achieve compliance with Rule 5550(a)(2), there can be no assurance
that the Company will be able to regain compliance with that rule or will otherwise be in compliance with other Nasdaq continued listing
requirements.
The
Company, by filing this Form 8-K, discloses its receipt of the letter in accordance with Nasdaq Listing Rule 5810(b).